Share Price and Basic Stock Data
Last Updated: October 22, 2025, 5:06 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Sundaram Multi Pap Ltd operates within the Printing, Publishing, and Stationery industry, with a current market capitalization of ₹88.6 Cr and a share price of ₹1.87. The company’s revenue has exhibited fluctuations over recent quarters, with sales recorded at ₹25.96 Cr in June 2022, peaking at ₹42.29 Cr in June 2023. However, the sales figures have shown variability, declining to ₹22.30 Cr in September 2023 before recovering to ₹40.51 Cr in March 2024. This trend highlights the company’s capacity to rebound from lower sales periods, although the overall annual sales from March 2022 to March 2025 suggest modest growth from ₹70 Cr to ₹127 Cr. The operating profit margins (OPM) have fluctuated significantly, with the highest OPM of 16% reported in March 2022, but dwindling to 1% by March 2025. This indicates challenges in maintaining profitability amid volatile sales, typical in the competitive printing sector where margins can be tight.
Profitability and Efficiency Metrics
The profitability of Sundaram Multi Pap Ltd has faced challenges, as evidenced by a recorded net profit of -₹5 Cr for the latest financial year, reflecting ongoing operational difficulties. The company’s operating profit margin (OPM) has fluctuated, with a low of -2.93% in March 2025, underscoring the pressure on profitability in recent quarters. The return on equity (ROE) stood at 5.92%, while the return on capital employed (ROCE) was significantly lower at 2.20%, indicating less effective utilization of capital. The interest coverage ratio (ICR) of 2.28x suggests a moderate ability to cover interest expenses, but the company’s cash conversion cycle of 159 days indicates inefficiencies in managing working capital. This prolonged cycle may hinder liquidity and operational agility, particularly in an industry where cash flow is crucial for sustaining operations and growth.
Balance Sheet Strength and Financial Ratios
Sundaram Multi Pap Ltd’s balance sheet reflects a mix of strengths and weaknesses. Total borrowings are reported at ₹27 Cr, which, alongside reserves of ₹40 Cr, indicates a relatively moderate debt position. The debt-to-equity ratio is notably low, suggesting a cautious approach to leveraging, which is generally favorable. However, the price-to-book value (P/BV) ratio of 0.60x suggests that the market may undervalue the company’s assets relative to its equity. The current ratio stands at 1.63x and the quick ratio at 0.94x, indicating decent liquidity to meet short-term obligations, although the quick ratio suggests potential liquidity constraints. Furthermore, the company’s total assets have declined from ₹299 Cr in March 2014 to ₹122 Cr in March 2025, reflecting a significant reduction in asset base which may impact future operational capacity.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sundaram Multi Pap Ltd indicates a stable structure, with promoters holding 31.11% of the company as of March 2025. The public holds a significant portion at 68.83%, while foreign institutional investors (FIIs) have no reported holdings, and domestic institutional investors (DIIs) represent a mere 0.05%. This lack of institutional interest could reflect investor hesitation tied to the company’s financial performance. The number of shareholders has steadily risen, from 51,872 in September 2022 to 95,643 by March 2025, suggesting growing public interest or confidence despite the financial challenges. This increase in shareholder count may indicate a potential for future capital influx, which could be pivotal for addressing operational inefficiencies and driving growth, should the company successfully navigate its current challenges.
Outlook, Risks, and Final Insight
If margins sustain improvement and the company effectively manages its cash conversion cycle, there could be a pathway for profitability enhancement. However, risks remain, particularly given the ongoing volatility in sales and profitability metrics. The reliance on a high public shareholder base without significant institutional backing may pose challenges in raising capital for future growth initiatives. The company must focus on improving operational efficiencies and controlling costs to stabilize profit margins. Additionally, maintaining a strong balance sheet while addressing the declining asset base will be crucial for future performance. Overall, Sundaram Multi Pap Ltd stands at a critical juncture; successful navigation of its operational challenges could enable it to leverage its market position effectively, while failure to do so may hinder its growth prospects significantly.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Sundaram Multi Pap Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| H T Media Ltd | 615 Cr. | 26.4 | 28.6/14.5 | 33.3 | 71.6 | 0.00 % | 2.51 % | 0.03 % | 2.00 |
| Gala Global Products Ltd | 13.9 Cr. | 2.55 | 4.25/2.37 | 6.97 | 0.00 % | 2.28 % | 13.0 % | 5.00 | |
| Flair Writing Industries Ltd | 3,289 Cr. | 312 | 357/194 | 29.0 | 95.0 | 0.32 % | 15.6 % | 11.9 % | 5.00 |
| Doms Industries Ltd | 15,319 Cr. | 2,524 | 3,115/2,092 | 73.7 | 165 | 0.12 % | 26.2 % | 22.3 % | 10.0 |
| DB Corp Ltd | 4,472 Cr. | 251 | 344/189 | 13.0 | 129 | 4.78 % | 21.1 % | 16.7 % | 10.0 |
| Industry Average | 2,619.00 Cr | 446.07 | 42.08 | 202.39 | 1.07% | 9.42% | 9.72% | 6.27 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.96 | 25.38 | 22.02 | 41.01 | 42.29 | 22.30 | 21.94 | 40.51 | 42.42 | 24.00 | 21.36 | 39.65 | 40.66 |
| Expenses | 21.18 | 21.85 | 22.11 | 39.98 | 40.06 | 22.54 | 22.41 | 37.93 | 38.69 | 24.04 | 22.26 | 40.81 | 39.52 |
| Operating Profit | 4.78 | 3.53 | -0.09 | 1.03 | 2.23 | -0.24 | -0.47 | 2.58 | 3.73 | -0.04 | -0.90 | -1.16 | 1.14 |
| OPM % | 18.41% | 13.91% | -0.41% | 2.51% | 5.27% | -1.08% | -2.14% | 6.37% | 8.79% | -0.17% | -4.21% | -2.93% | 2.80% |
| Other Income | 0.77 | 0.46 | 0.72 | -0.58 | -1.16 | -0.32 | 0.38 | -0.48 | -1.79 | -0.10 | 0.10 | 2.06 | 0.16 |
| Interest | 1.35 | 1.02 | 1.14 | 0.59 | 0.93 | 0.77 | 0.98 | 0.78 | 0.62 | 0.61 | 0.79 | 0.66 | 0.70 |
| Depreciation | 0.97 | 0.97 | 0.97 | 0.98 | 0.97 | 1.02 | 1.07 | 1.08 | 1.06 | 1.09 | 1.10 | 1.09 | 1.04 |
| Profit before tax | 3.23 | 2.00 | -1.48 | -1.12 | -0.83 | -2.35 | -2.14 | 0.24 | 0.26 | -1.84 | -2.69 | -0.85 | -0.44 |
| Tax % | 0.00% | 0.00% | 5.41% | -3.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 3.23 | 2.00 | -1.56 | -1.07 | -0.83 | -2.35 | -2.14 | 0.24 | 0.25 | -1.83 | -2.69 | -0.85 | -0.44 |
| EPS in Rs | 0.07 | 0.04 | -0.03 | -0.02 | -0.02 | -0.05 | -0.05 | 0.01 | 0.01 | -0.04 | -0.06 | -0.02 | -0.01 |
Last Updated: August 20, 2025, 2:55 am
Below is a detailed analysis of the quarterly data for Sundaram Multi Pap Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 40.66 Cr.. The value appears strong and on an upward trend. It has increased from 39.65 Cr. (Mar 2025) to 40.66 Cr., marking an increase of 1.01 Cr..
- For Expenses, as of Jun 2025, the value is 39.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 40.81 Cr. (Mar 2025) to 39.52 Cr., marking a decrease of 1.29 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.14 Cr.. The value appears strong and on an upward trend. It has increased from -1.16 Cr. (Mar 2025) to 1.14 Cr., marking an increase of 2.30 Cr..
- For OPM %, as of Jun 2025, the value is 2.80%. The value appears strong and on an upward trend. It has increased from -2.93% (Mar 2025) to 2.80%, marking an increase of 5.73%.
- For Other Income, as of Jun 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 2.06 Cr. (Mar 2025) to 0.16 Cr., marking a decrease of 1.90 Cr..
- For Interest, as of Jun 2025, the value is 0.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.66 Cr. (Mar 2025) to 0.70 Cr., marking an increase of 0.04 Cr..
- For Depreciation, as of Jun 2025, the value is 1.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.09 Cr. (Mar 2025) to 1.04 Cr., marking a decrease of 0.05 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.44 Cr.. The value appears strong and on an upward trend. It has increased from -0.85 Cr. (Mar 2025) to -0.44 Cr., marking an increase of 0.41 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.44 Cr.. The value appears strong and on an upward trend. It has increased from -0.85 Cr. (Mar 2025) to -0.44 Cr., marking an increase of 0.41 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.01. The value appears strong and on an upward trend. It has increased from -0.02 (Mar 2025) to -0.01, marking an increase of 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:21 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 154 | 83 | 96 | 94 | 106 | 100 | 97 | 51 | 70 | 114 | 127 | 127 | 126 |
| Expenses | 135 | 82 | 84 | 79 | 95 | 85 | 90 | 52 | 59 | 105 | 123 | 126 | 127 |
| Operating Profit | 19 | 1 | 12 | 15 | 12 | 15 | 7 | -1 | 11 | 10 | 4 | 2 | -1 |
| OPM % | 12% | 1% | 12% | 16% | 11% | 15% | 7% | -3% | 16% | 8% | 3% | 1% | -1% |
| Other Income | 3 | 0 | -4 | -8 | -16 | 2 | 5 | 2 | 2 | 1 | -2 | 0 | 2 |
| Interest | 17 | 16 | 12 | 10 | 9 | 7 | 10 | 6 | 5 | 4 | 4 | 3 | 3 |
| Depreciation | 5 | 3 | 3 | 2 | 2 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 1 | -17 | -8 | -5 | -15 | 6 | -3 | -9 | 4 | 3 | -5 | -5 | -6 |
| Tax % | 85% | -4% | -18% | -0% | 0% | 0% | 0% | -2% | 3% | 2% | 0% | 0% | |
| Net Profit | 0 | -17 | -6 | -5 | -15 | 6 | -3 | -9 | 4 | 3 | -5 | -5 | -6 |
| EPS in Rs | 0.00 | -0.78 | -0.30 | -0.20 | -0.55 | 0.22 | -0.10 | -0.19 | 0.08 | 0.05 | -0.11 | -0.11 | -0.13 |
| Dividend Payout % | 216% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 64.71% | 16.67% | -200.00% | 140.00% | -150.00% | -200.00% | 144.44% | -25.00% | -266.67% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -48.04% | -216.67% | 340.00% | -290.00% | -50.00% | 344.44% | -169.44% | -241.67% | 266.67% |
Sundaram Multi Pap Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 6% |
| 3 Years: | 22% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | % |
| TTM: | -281% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 9% |
| 3 Years: | -15% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -1% |
| 3 Years: | 0% |
| Last Year: | -4% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: June 16, 2025, 11:17 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 25 | 27 | 47 | 47 | 47 | 47 | 47 | 47 | 47 |
| Reserves | 137 | 91 | 80 | 79 | 69 | 55 | 52 | 44 | 48 | 50 | 45 | 40 |
| Borrowings | 116 | 103 | 91 | 64 | 56 | 43 | 45 | 44 | 39 | 35 | 32 | 27 |
| Other Liabilities | 24 | 17 | 14 | 30 | 23 | 17 | 13 | 13 | 12 | 6 | 10 | 7 |
| Total Liabilities | 299 | 232 | 207 | 196 | 175 | 163 | 158 | 148 | 146 | 138 | 135 | 122 |
| Fixed Assets | 131 | 96 | 87 | 54 | 53 | 67 | 64 | 60 | 57 | 71 | 69 | 51 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 15 | 15 | 25 | 39 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 153 | 121 | 94 | 104 | 84 | 96 | 94 | 88 | 89 | 67 | 65 | 71 |
| Total Assets | 299 | 232 | 207 | 196 | 175 | 163 | 158 | 148 | 146 | 138 | 135 | 122 |
Below is a detailed analysis of the balance sheet data for Sundaram Multi Pap Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 47.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 47.00 Cr..
- For Reserves, as of Mar 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Mar 2024) to 40.00 Cr., marking a decrease of 5.00 Cr..
- For Borrowings, as of Mar 2025, the value is 27.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 32.00 Cr. (Mar 2024) to 27.00 Cr., marking a decrease of 5.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing). It has decreased from 10.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 3.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 122.00 Cr.. The value appears to be improving (decreasing). It has decreased from 135.00 Cr. (Mar 2024) to 122.00 Cr., marking a decrease of 13.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2024) to 51.00 Cr., marking a decrease of 18.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 71.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Mar 2024) to 71.00 Cr., marking an increase of 6.00 Cr..
- For Total Assets, as of Mar 2025, the value is 122.00 Cr.. The value appears to be declining and may need further review. It has decreased from 135.00 Cr. (Mar 2024) to 122.00 Cr., marking a decrease of 13.00 Cr..
Notably, the Reserves (40.00 Cr.) exceed the Borrowings (27.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -97.00 | -102.00 | -79.00 | -49.00 | -44.00 | -28.00 | -38.00 | -45.00 | -28.00 | -25.00 | -28.00 | -25.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116 | 95 | 103 | 96 | 56 | 78 | 64 | 126 | 82 | 40 | 34 | 42 |
| Inventory Days | 191 | 340 | 207 | 131 | 173 | 213 | 201 | 301 | 283 | 155 | 151 | 128 |
| Days Payable | 44 | 50 | 47 | 65 | 83 | 45 | 13 | 51 | 28 | 11 | 24 | 11 |
| Cash Conversion Cycle | 262 | 385 | 263 | 162 | 146 | 246 | 252 | 376 | 337 | 185 | 161 | 159 |
| Working Capital Days | 80 | 225 | 45 | 60 | 51 | 156 | 216 | 369 | 276 | 156 | 134 | 78 |
| ROCE % | 7% | 1% | 6% | 8% | 8% | 9% | 3% | -2% | 8% | 7% | 0% | -2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.21 | -0.73 | -0.27 | -0.40 | -1.05 |
| Diluted EPS (Rs.) | 0.21 | -0.73 | -0.27 | -0.40 | -1.05 |
| Cash EPS (Rs.) | 0.34 | -0.59 | -0.12 | -0.21 | -0.80 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 3.53 | 2.56 | 3.28 | 3.79 | 4.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 3.53 | 2.56 | 3.28 | 3.79 | 4.41 |
| Revenue From Operations / Share (Rs.) | 3.67 | 4.00 | 4.04 | 4.57 | 3.94 |
| PBDIT / Share (Rs.) | 0.61 | 0.54 | 0.78 | 0.59 | 0.06 |
| PBIT / Share (Rs.) | 0.51 | 0.44 | 0.66 | 0.41 | -0.18 |
| PBT / Share (Rs.) | 0.24 | -0.56 | -0.18 | -0.47 | -1.09 |
| Net Profit / Share (Rs.) | 0.24 | -0.69 | -0.25 | -0.40 | -1.05 |
| NP After MI And SOA / Share (Rs.) | 0.24 | -0.69 | -0.25 | -0.40 | -1.05 |
| PBDIT Margin (%) | 16.90 | 13.68 | 19.42 | 13.08 | 1.57 |
| PBIT Margin (%) | 14.05 | 11.20 | 16.34 | 9.03 | -4.65 |
| PBT Margin (%) | 6.63 | -14.01 | -4.67 | -10.32 | -27.56 |
| Net Profit Margin (%) | 6.63 | -17.36 | -6.21 | -8.84 | -26.69 |
| NP After MI And SOA Margin (%) | 6.63 | -17.36 | -6.21 | -8.84 | -26.69 |
| Return on Networth / Equity (%) | 8.75 | -27.09 | -7.66 | -10.67 | -23.85 |
| Return on Capital Employeed (%) | 14.51 | 15.30 | 16.87 | 8.41 | -2.70 |
| Return On Assets (%) | 4.28 | -12.41 | -3.46 | -4.58 | -10.36 |
| Long Term Debt / Equity (X) | 0.00 | 0.13 | 0.18 | 0.26 | 0.49 |
| Total Debt / Equity (X) | 0.49 | 0.76 | 0.76 | 0.83 | 0.90 |
| Asset Turnover Ratio (%) | 0.59 | 0.60 | 0.48 | 0.45 | 0.32 |
| Current Ratio (X) | 1.63 | 1.31 | 1.29 | 1.03 | 1.45 |
| Quick Ratio (X) | 0.94 | 0.76 | 0.95 | 0.49 | 0.52 |
| Inventory Turnover Ratio (X) | 1.58 | 2.18 | 1.79 | 1.10 | 0.92 |
| Interest Coverage Ratio (X) | 2.28 | 1.67 | 1.73 | 1.06 | 0.08 |
| Interest Coverage Ratio (Post Tax) (X) | 1.89 | 0.95 | 1.32 | 0.84 | -0.19 |
| Enterprise Value (Cr.) | 103.53 | 129.21 | 128.33 | 115.10 | 130.25 |
| EV / Net Operating Revenue (X) | 1.04 | 1.19 | 1.29 | 1.17 | 1.53 |
| EV / EBITDA (X) | 6.15 | 8.69 | 6.66 | 8.93 | 97.11 |
| MarketCap / Net Operating Revenue (X) | 0.46 | 0.70 | 0.67 | 0.49 | 0.53 |
| Price / BV (X) | 0.60 | 1.10 | 0.83 | 0.59 | 0.47 |
| Price / Net Operating Revenue (X) | 0.46 | 0.70 | 0.67 | 0.49 | 0.53 |
| EarningsYield | 0.14 | -0.24 | -0.09 | -0.17 | -0.50 |
After reviewing the key financial ratios for Sundaram Multi Pap Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 19, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 18) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 19, the value is 0.21. This value is below the healthy minimum of 5. It has increased from -0.73 (Mar 18) to 0.21, marking an increase of 0.94.
- For Diluted EPS (Rs.), as of Mar 19, the value is 0.21. This value is below the healthy minimum of 5. It has increased from -0.73 (Mar 18) to 0.21, marking an increase of 0.94.
- For Cash EPS (Rs.), as of Mar 19, the value is 0.34. This value is below the healthy minimum of 3. It has increased from -0.59 (Mar 18) to 0.34, marking an increase of 0.93.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 3.53. It has increased from 2.56 (Mar 18) to 3.53, marking an increase of 0.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 3.53. It has increased from 2.56 (Mar 18) to 3.53, marking an increase of 0.97.
- For Revenue From Operations / Share (Rs.), as of Mar 19, the value is 3.67. It has decreased from 4.00 (Mar 18) to 3.67, marking a decrease of 0.33.
- For PBDIT / Share (Rs.), as of Mar 19, the value is 0.61. This value is below the healthy minimum of 2. It has increased from 0.54 (Mar 18) to 0.61, marking an increase of 0.07.
- For PBIT / Share (Rs.), as of Mar 19, the value is 0.51. This value is within the healthy range. It has increased from 0.44 (Mar 18) to 0.51, marking an increase of 0.07.
- For PBT / Share (Rs.), as of Mar 19, the value is 0.24. This value is within the healthy range. It has increased from -0.56 (Mar 18) to 0.24, marking an increase of 0.80.
- For Net Profit / Share (Rs.), as of Mar 19, the value is 0.24. This value is below the healthy minimum of 2. It has increased from -0.69 (Mar 18) to 0.24, marking an increase of 0.93.
- For NP After MI And SOA / Share (Rs.), as of Mar 19, the value is 0.24. This value is below the healthy minimum of 2. It has increased from -0.69 (Mar 18) to 0.24, marking an increase of 0.93.
- For PBDIT Margin (%), as of Mar 19, the value is 16.90. This value is within the healthy range. It has increased from 13.68 (Mar 18) to 16.90, marking an increase of 3.22.
- For PBIT Margin (%), as of Mar 19, the value is 14.05. This value is within the healthy range. It has increased from 11.20 (Mar 18) to 14.05, marking an increase of 2.85.
- For PBT Margin (%), as of Mar 19, the value is 6.63. This value is below the healthy minimum of 10. It has increased from -14.01 (Mar 18) to 6.63, marking an increase of 20.64.
- For Net Profit Margin (%), as of Mar 19, the value is 6.63. This value is within the healthy range. It has increased from -17.36 (Mar 18) to 6.63, marking an increase of 23.99.
- For NP After MI And SOA Margin (%), as of Mar 19, the value is 6.63. This value is below the healthy minimum of 8. It has increased from -17.36 (Mar 18) to 6.63, marking an increase of 23.99.
- For Return on Networth / Equity (%), as of Mar 19, the value is 8.75. This value is below the healthy minimum of 15. It has increased from -27.09 (Mar 18) to 8.75, marking an increase of 35.84.
- For Return on Capital Employeed (%), as of Mar 19, the value is 14.51. This value is within the healthy range. It has decreased from 15.30 (Mar 18) to 14.51, marking a decrease of 0.79.
- For Return On Assets (%), as of Mar 19, the value is 4.28. This value is below the healthy minimum of 5. It has increased from -12.41 (Mar 18) to 4.28, marking an increase of 16.69.
- For Long Term Debt / Equity (X), as of Mar 19, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 18) to 0.00, marking a decrease of 0.13.
- For Total Debt / Equity (X), as of Mar 19, the value is 0.49. This value is within the healthy range. It has decreased from 0.76 (Mar 18) to 0.49, marking a decrease of 0.27.
- For Asset Turnover Ratio (%), as of Mar 19, the value is 0.59. It has decreased from 0.60 (Mar 18) to 0.59, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 19, the value is 1.63. This value is within the healthy range. It has increased from 1.31 (Mar 18) to 1.63, marking an increase of 0.32.
- For Quick Ratio (X), as of Mar 19, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.76 (Mar 18) to 0.94, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 19, the value is 1.58. This value is below the healthy minimum of 4. It has decreased from 2.18 (Mar 18) to 1.58, marking a decrease of 0.60.
- For Interest Coverage Ratio (X), as of Mar 19, the value is 2.28. This value is below the healthy minimum of 3. It has increased from 1.67 (Mar 18) to 2.28, marking an increase of 0.61.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 19, the value is 1.89. This value is below the healthy minimum of 3. It has increased from 0.95 (Mar 18) to 1.89, marking an increase of 0.94.
- For Enterprise Value (Cr.), as of Mar 19, the value is 103.53. It has decreased from 129.21 (Mar 18) to 103.53, marking a decrease of 25.68.
- For EV / Net Operating Revenue (X), as of Mar 19, the value is 1.04. This value is within the healthy range. It has decreased from 1.19 (Mar 18) to 1.04, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 19, the value is 6.15. This value is within the healthy range. It has decreased from 8.69 (Mar 18) to 6.15, marking a decrease of 2.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 19, the value is 0.46. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 18) to 0.46, marking a decrease of 0.24.
- For Price / BV (X), as of Mar 19, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 1.10 (Mar 18) to 0.60, marking a decrease of 0.50.
- For Price / Net Operating Revenue (X), as of Mar 19, the value is 0.46. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 18) to 0.46, marking a decrease of 0.24.
- For EarningsYield, as of Mar 19, the value is 0.14. This value is below the healthy minimum of 5. It has increased from -0.24 (Mar 18) to 0.14, marking an increase of 0.38.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sundaram Multi Pap Ltd:
- Net Profit Margin: 6.63%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.51% (Industry Average ROCE: 9.42%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.75% (Industry Average ROE: 9.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.89
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.94
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 42.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.49
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.63%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Printing/Publishing/Stationery | 5/6, Papa Industrial Estate, Mumbai Maharashtra 400093 | info@sundaramgroups.in http://www.sundaramgroups.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Amrut P Shah | Chairman & Managing Director |
| Mr. Shantilal P Shah | Whole Time Director |
| Mr. Krunal S Shah | Whole Time Director |
| Mr. Kalpesh B Parekh | Independent Director |
| Mr. Mahesh Devji Bhanushali | Independent Director |
| Ms. Jyoti C Gala | Independent Woman Director |
FAQ
What is the intrinsic value of Sundaram Multi Pap Ltd?
Sundaram Multi Pap Ltd's intrinsic value (as of 25 October 2025) is 1.34 which is 29.10% lower the current market price of 1.89, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 89.6 Cr. market cap, FY2025-2026 high/low of 2.97/1.77, reserves of ₹40 Cr, and liabilities of 122 Cr.
What is the Market Cap of Sundaram Multi Pap Ltd?
The Market Cap of Sundaram Multi Pap Ltd is 89.6 Cr..
What is the current Stock Price of Sundaram Multi Pap Ltd as on 25 October 2025?
The current stock price of Sundaram Multi Pap Ltd as on 25 October 2025 is 1.89.
What is the High / Low of Sundaram Multi Pap Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sundaram Multi Pap Ltd stocks is 2.97/1.77.
What is the Stock P/E of Sundaram Multi Pap Ltd?
The Stock P/E of Sundaram Multi Pap Ltd is .
What is the Book Value of Sundaram Multi Pap Ltd?
The Book Value of Sundaram Multi Pap Ltd is 1.85.
What is the Dividend Yield of Sundaram Multi Pap Ltd?
The Dividend Yield of Sundaram Multi Pap Ltd is 0.00 %.
What is the ROCE of Sundaram Multi Pap Ltd?
The ROCE of Sundaram Multi Pap Ltd is 2.20 %.
What is the ROE of Sundaram Multi Pap Ltd?
The ROE of Sundaram Multi Pap Ltd is 5.92 %.
What is the Face Value of Sundaram Multi Pap Ltd?
The Face Value of Sundaram Multi Pap Ltd is 1.00.
